Volta Medical’s RESTART Trial Shows Promising Findings for AI Solutions in Recurrent Atrial Fibrillation
MARSEILLE, France, Feb. 3, 2026 /PRNewswire/ — Volta Medical, committed to revolutionizing care for underserved complex AF patients with breakthrough AI solutions, announced results from the RESTART trial, published in Heart Rhythm.
